USANA Health Sciences, Inc. (NYSE:USNA – Get Free Report) Director John Turman Fleming sold 500 shares of the stock in a transaction on Tuesday, March 11th. The shares were sold at an average price of $33.30, for a total value of $16,650.00. Following the sale, the director now owns 4,026 shares in the company, valued at approximately $134,065.80. This trade represents a 11.05 % decrease in their position. The sale was disclosed in a legal filing with the SEC, which is available through this link.
USANA Health Sciences Stock Down 6.5 %
Shares of USANA Health Sciences stock opened at $30.38 on Friday. USANA Health Sciences, Inc. has a fifty-two week low of $27.71 and a fifty-two week high of $50.32. The firm has a market cap of $579.12 million, a PE ratio of 10.74, a P/E/G ratio of 0.93 and a beta of 0.98. The business’s fifty day moving average is $32.79 and its two-hundred day moving average is $36.05.
USANA Health Sciences (NYSE:USNA – Get Free Report) last issued its earnings results on Tuesday, February 25th. The company reported $0.64 earnings per share for the quarter, topping the consensus estimate of $0.49 by $0.15. The business had revenue of $213.61 million for the quarter, compared to analyst estimates of $208.82 million. USANA Health Sciences had a return on equity of 10.64% and a net margin of 6.30%. Equities research analysts anticipate that USANA Health Sciences, Inc. will post 2.45 EPS for the current year.
Institutional Inflows and Outflows
Wall Street Analyst Weigh In
USNA has been the topic of a number of analyst reports. Sidoti cut USANA Health Sciences from a “strong-buy” rating to a “hold” rating in a report on Tuesday, February 18th. StockNews.com lowered USANA Health Sciences from a “strong-buy” rating to a “buy” rating in a research note on Friday, February 14th. Finally, DA Davidson reduced their price target on USANA Health Sciences from $38.00 to $36.00 and set a “neutral” rating on the stock in a research note on Thursday, February 27th.
Get Our Latest Analysis on USNA
USANA Health Sciences Company Profile
USANA Health Sciences, Inc develops, manufactures, and sells science-based nutritional, personal care, and skincare products in the Asia Pacific, the Americas, and Europe. The company offers USANA nutritional products that comprise essentials/CellSentials, such as vitamin and mineral supplements that provide a foundation of total body nutrition for various age groups; optimizers consisting of targeted supplements that are designed to meet cardiovascular, skeletal/structural, and digestive health needs; and food that include meal replacement shakes, snack bars, and other related products.
Read More
- Five stocks we like better than USANA Health Sciences
- Stock Sentiment Analysis: How it Works
- 3 Undervalued Stocks You Can Buy at a Discount Now
- 3 Monster Growth Stocks to Buy Now
- AMD Stock: Can the PC Refresh Cycle Spark a Rally?
- Golden Cross Stocks: Pattern, Examples and Charts
- Micron Stock Spikes 7%—3 Key Catalysts Behind the Move
Receive News & Ratings for USANA Health Sciences Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for USANA Health Sciences and related companies with MarketBeat.com's FREE daily email newsletter.